Securities Code: 002020
Securities Abbreviation: Jingxin Pharmaceutical
Announcement No.: 2026041
Jingxin Pharmaceutical Co., Ltd.
2026 Second Extraordinary General Meeting Resolution Announcement
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed in this announcement, and that there are no false records, misleading statements, or significant omissions.
Important Notes:
-
There were no proposals rejected at this general meeting.
-
This general meeting does not involve any changes to resolutions previously passed by the shareholders' meeting.
I. Meeting Convening Situation
- Time of Convening of this General Meeting
On-site Meeting Time: Starting from 14:00 on July 20, 2026.
Online Voting: The specific time for online voting through the Shenzhen Stock Exchange trading system is July 20, 2026, from 9:15-9:25, 9:30-11:30, and 13:00-15:00; the specific time for online voting through the Shenzhen Stock Exchange internet voting system is any time from 9:15 to 15:00 on July 20, 2026.
-
On-site Meeting Location: First-floor conference room of the administrative building of the Company, No. 800, Xinchang Avenue East Road, Yulin Subdistrict, Xinchang County, Zhejiang Province.
-
Method of Convening the Meeting: This meeting adopted a combination of on-site voting and online voting. This general meeting provides an online voting platform for the company's shareholders through the Shenzhen Stock Exchange trading system and the internet voting system. Shareholders can exercise their voting rights through the aforementioned systems during the online voting period.
-
Convenor of the Meeting: The Board of Directors of Jingxin Pharmaceutical Co., Ltd.
-
Presider of the Meeting: Mr. Wang Nengneng, Vice Chairman of the Company.
-
The convening, holding, and voting procedures of this meeting comply with relevant laws, regulations, rules, and the Company's Articles of Association.
II. Meeting Attendance Situation
In accordance with the relevant provisions of the "Shenzhen Stock Exchange Listed Company Self-Regulation Guidelines No. 9 - Share Repurchases," shares held in the dedicated repurchase account of a listed company do not carry voting rights at general meetings. Accordingly, when calculating the total number of shares with voting rights, shares in the dedicated repurchase account should be deducted. Therefore, the total number of shares with voting rights at this general meeting is 820,881,245 shares (after deducting 40,147,895 shares in the dedicated repurchase securities account as of the share registration date).
- Overall Situation of Attending Shareholders
A total of 301 shareholders and their proxies attended the on-site and online voting for this general meeting, representing 348,455,090 shares, accounting for 42.4489% of the total shares with voting rights.
- On-site Meeting Attendance Situation
A total of 3 shareholders and their proxies attended the on-site meeting, representing 4,041,486 shares, accounting for 0.4923% of the total shares with voting rights.
- Online Voting Situation
298 shareholders voted online, representing 344,413,604 shares, accounting for 41.9566% of the total shares with voting rights.
- Attendance of Small and Medium Investors
A total of 297 small and medium investors (defined as shareholders other than the company's directors, supervisors, senior management, and shareholders who individually or collectively hold more than 5% of the company's shares) participated in the voting for this general meeting, representing 30,740,956 shares, accounting for 3.7449% of the total shares with voting rights.